← Back to headlines
AtriCure Aims for 12%-14% Revenue Growth by 2026 Driven by Innovation
AtriCure is targeting a 12%-14% revenue growth by 2026, attributing this projected momentum to ongoing innovation and significant clinical progress.
18 Feb, 00:25 — 18 Feb, 00:25
Read at source (1 outlet)
Related Stories
South Korea's US Import Share Declines Amid Tariff Uncertainty
8m ago
Glaukos Projects $600M-$620M Sales by 2026 Driven by iDose TR and Epioxa
8m ago
Businesses Scramble to Reach China's Growing Experiences Economy Ahead of Lunar New Year
18m ago
Budweiser and Heineken Face Contrasting Fortunes in Chinese Market
28m ago